Sun Changbo, Anraku Masaki, Kawahara Takuya, Karasaki Takahiro, Kitano Kentaro, Nagayama Kazuhiro, Sato Masaaki, Nakajima Jun
Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Tokyo, Japan; Department of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China.
Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Lung Cancer. 2020 Sep;147:71-76. doi: 10.1016/j.lungcan.2020.07.008. Epub 2020 Jul 7.
The impact of sarcopenia on the outcome in patients following resection of non-small cell lung cancer is yet to be fully determined. This study aimed to evaluate the clinical utility of a computed tomography-based pectoralis muscle assessment, which reflects sarcopenia, to predict the risk of postoperative outcomes.
This retrospective study included 347 consecutive patients undergoing curative-intent resection of non-small cell lung cancer from 2009 to 2013. The pectoralis muscle index (pectoralis muscle area/body mass index) was assessed at the level of the fourth thoracic vertebra on chest axial images. The primary outcomes were compared between the lowest gender-specific quintile (sarcopenia) and the other quintiles according to the index. The prognostic significance of low pectoralis muscle index was calculated by the Cox proportional hazards regression model. A propensity score matching analysis was performed to adjust the differences in clinical characteristics.
Sixty-nine patients were identified with sarcopenia according to the lowest gender-specific quintile of pectoralis muscle index. Patients with sarcopenia exhibited worse 5-year overall survival rate compared with patients without sarcopenia (64.2 % vs. 86.7 %, P < 0.001). Even in stage I non-small cell lung cancer, the rate of 5-year overall survival in the sarcopenia group was lower than that in the non-sarcopenia group (74.2 % vs. 92.4 %, P = 0.001). Multivariate analysis revealed that low pectoralis muscle index was independently associated with adverse overall survival (hazard ratio: 2.09, 95 % confidence interval: 1.20-3.62, P = 0.009). After propensity score matching, the prognostic impact of sarcopenia based on low pectoralis muscle index was also robust for overall survival (hazard ratio: 3.23, 95 % confidence interval: 1.38-7.60, P = 0.007).
Low pectoralis muscle index was significantly associated with poor long-term outcomes in patients with localized non-small cell lung cancer after curative surgery. This may help assist preoperative risk stratification and longitudinal management after surgery.
肌肉减少症对非小细胞肺癌切除术后患者预后的影响尚未完全明确。本研究旨在评估基于计算机断层扫描的反映肌肉减少症的胸肌评估在预测术后预后风险方面的临床效用。
这项回顾性研究纳入了2009年至2013年连续接受非小细胞肺癌根治性切除的347例患者。在胸部轴位图像上于第四胸椎水平评估胸肌指数(胸肌面积/体重指数)。根据该指数,比较最低性别特异性五分位数(肌肉减少症)与其他五分位数之间的主要结局。通过Cox比例风险回归模型计算低胸肌指数的预后意义。进行倾向评分匹配分析以调整临床特征的差异。
根据胸肌指数的最低性别特异性五分位数,确定69例患者存在肌肉减少症。与无肌肉减少症的患者相比,肌肉减少症患者的5年总生存率较差(64.2%对86.7%,P<0.001)。即使在I期非小细胞肺癌中,肌肉减少症组的5年总生存率也低于非肌肉减少症组(74.2%对92.4%,P=0.001)。多因素分析显示,低胸肌指数与不良总生存独立相关(风险比:2.09,95%置信区间:1.20 - 3.62,P=0.009)。倾向评分匹配后,基于低胸肌指数的肌肉减少症对总生存的预后影响也很显著(风险比:3.23,95%置信区间:l.38 - 7.60,P=0.007)。
低胸肌指数与局限性非小细胞肺癌根治性手术后患者的不良长期预后显著相关。这可能有助于术前风险分层及术后的纵向管理。